Kennedy Jr. Advocates for US-Driven Medical Future

The article emphasizes the United States' need to strengthen its clinical research sector to maintain leadership in medical innovation. It highlights recent efforts by government agencies to streamline clinical trials, reduce development timelines, and bring more research and investment back to the U.S. to prevent losing ground to countries like China, which now conducts more early-stage trials. These initiatives aim to enhance innovation, create high-skilled jobs, and improve patient access to new therapies while maintaining safety and ethical standards.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article